Glycozar-M 40 mg Tablet

Glycozar-M 40 mg Tablet contains Gliclazide modified release 40 mg. Prescription required.

Type 2 diabetes mellitus (adult) to improve blood glucose control along with diet and exercise; may be used alone or with other antidiabetic medicines as prescribed.

Gliclazide is a sulfonylurea antidiabetic. It stimulates insulin release from pancreatic beta cells and improves peripheral glucose utilization, thereby lowering blood sugar levels.

Take by mouth exactly as prescribed. Usually taken once daily with breakfast/first main meal; swallow tablet whole (do not crush/chew) if modified-release. Monitor blood glucose regularly and do not skip meals to reduce risk of hypoglycaemia.

Hypoglycaemia, dizziness, headache, nausea, abdominal pain, diarrhoea, constipation, weight gain, skin rash, itching

Risk of hypoglycaemia especially with missed meals, excess exercise, alcohol use, or dose changes. Use with caution in elderly, malnourished patients, and those with kidney or liver impairment. Not for type 1 diabetes or diabetic ketoacidosis. Inform doctor about recurrent low sugar episodes; carry glucose/sugar source. Rare but serious: severe allergic reactions, blood dyscrasias, liver dysfunction—seek medical help if jaundice, unusual bruising, fever/sore throat occur.

Alcohol (increases hypoglycaemia risk), other antidiabetics including insulin, beta-blockers (may mask hypoglycaemia), fluconazole (may increase gliclazide effect), rifampicin (may reduce effect), corticosteroids and thiazide diuretics (may raise glucose), warfarin (may enhance anticoagulant effect—monitor INR).

Store below 25°C in a dry place, protected from light and moisture. Keep in original blister pack and out of reach of children.

Diamicron MR 60 Tablet, Glyciphage 40 MR Tablet, Gliclazide MR 40 mg Tablet (generic), Glizid MR 40 Tablet, Reclide MR 40 Tablet